Stay updated on Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page.

Latest updates to the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLakefront Biotherapeutics NV was added as a collaborator for the study, indicating a new partner organization involved in the trial's governance and coordination. Galapagos NV was removed as a collaborator, reflecting a change in the study's partnership landscape.SummaryDifference0.0%

- Check19 days agoChange DetectedA new site revision tag (v3.5.4) was added, replacing the previous revision tag (v3.5.3). This indicates an update to the page's template or content management without altering the study details.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s release/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2, adding Revision: v3.5.2 and removing Revision: v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3. This is a minor version update.SummaryDifference0.0%

Stay in the know with updates to Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Efficacy in Perianal Fistulizing Crohn's Disease Clinical Trial page.